NEW YORK (Reuters) - Many of the largest U.S. pharmacies and drug distributors do not have Teva Pharmaceutical Industries Ltd's generic version of the life-saving EpiPen allergy treatment five months ...

JERUSALEM & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced availability of the FDA-approved generic version of EpiPen Jr®1 (epinephrine ...

(Reuters) - Teva Pharmaceutical Industries Ltd on Tuesday made its generic version of Mylan's EpiPen for young children available in most retail pharmacies at $300 for a 2-pack. U.S.-listed shares of ...

The FDA cleared the first generic version of EpiPen and EpiPen Jr, an epinephrine auto-injector for severe allergic reactions, 2 years after generic drugmaker Teva Pharmaceuticals was first turned ...

Mylan’s life-saving epinephrine auto-injector EpiPen now has a generic rival, the Food and Drug Administration (FDA) triumphantly announced. Teva Pharmaceuticals USA now has FDA approval to market a ...

Getting your Trinity Audio player ready... A bill in the Colorado legislature would allow stiffer penalties for EpiPen and insulin manufacturers who refuse to sell their products under the state’s ...

(Reuters) - Teva Pharmaceutical Industries Ltd said on Tuesday its generic version of Mylan NV's EpiPen will have a wholesale price of $300. The Israeli drugmaker also said its version of the ...

Israel-based Teva Pharmaceuticals seeks to earn Food and Drug Administration approval for its generic version of Mylan’s EpiPen by late 2017 or early 2018. In February, the FDA failed to approve ...

(Reuters) -Viatris Inc, the drugmaker formerly known as Mylan, said on Monday it had agreed to pay $264 million to resolve a class action lawsuit alleging it engaged in a scheme to delay generic ...

TEL AVIV, Feb 19 (Reuters) - Teva Pharmaceutical Industries expects its generic version of Mylan's EpiPen to have about 25 percent of the U.S. market by the end of 2019, Chief Executive Kare Schultz ...

The U.S. Food and Drug Administration has approved the first generic competitor to EpiPen and EpiPen Jr. for the emergency treatment of allergic reactions in adults and children. The company Teva ...